Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Clopidogrel + aspirine versus aspirine seule pour la prévention de la maladie cardio‐vasculaire

Esta versión no es la más reciente

ver la versión actual 14 diciembre 2017

Información

DOI:
https://doi.org/10.1002/14651858.CD005158.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 19 enero 2011see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Corazón

Copyright:
  1. Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Alessandro Squizzato

    Correspondencia a: Research Center on Thromboembolic Disorders and Antithrombotic Therapies, Department of Clinical Medicine, University of Insubria, Varese, Italy

    [email protected]

    [email protected]

  • Tymen Keller

    Cardiology, Academical Medical Center, Amsterdam, Netherlands

  • Erica Romualdi

    Department of Clinical Medicine, University of Insubria, Varese, Italy

  • Saskia Middeldorp

    Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands

Contributions of authors

Squizzato
Guarantor of the review. Conception and design of the study. Data collection. Analysis and interpretation of data, providing a clinical perspective. Drafting the review. Final approval of the version to be published

Keller
Conception and design of the study. Data collection. Analysis and interpretation of data. Revising the review critically for important intellectual content. Final approval of the version to be published

Romualdi

Data collection. Analysis and interpretation of data, providing a methodological perspective. Revising the review critically for important intellectual content. Final approval of the version to be published

Middeldorp
Conception, design and coordination of the study. Analysis and interpretation of data, providing a methodological perspective. Revising the review critically for important intellectual content. Final approval of the version to be published

Sources of support

Internal sources

  • Academic Medical Center, Netherlands.

  • University of Insubria, Italy.

External sources

  • No sources of support supplied

Declarations of interest

Keller was involved as sub‐investigator in the CHARISMA study

Acknowledgements

The authors thank Prof. Steven R. Steinhubl for providing additional data of the CREDO study.

Version history

Published

Title

Stage

Authors

Version

2017 Dec 14

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events

Review

Alessandro Squizzato, Marta Bellesini, Andrea Takeda, Saskia Middeldorp, Marco Paolo Donadini

https://doi.org/10.1002/14651858.CD005158.pub4

2011 Jan 19

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease

Review

Alessandro Squizzato, Tymen Keller, Erica Romualdi, Saskia Middeldorp

https://doi.org/10.1002/14651858.CD005158.pub3

2007 Jul 18

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease

Review

Alessandro Squizzato, Tymen Keller, Saskia Middeldorp

https://doi.org/10.1002/14651858.CD005158.pub2

2005 Jan 24

Clopidogrel and aspirin versus aspirin for preventing cardiovascular disease in those at high risk

Protocol

Tymen Keller, Alessandro Squizzato, Viola B Weeda, Saskia Middeldorp

https://doi.org/10.1002/14651858.CD005158

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.